INNOPEUTICS
LIVE

Serial Number

79445256

Owner

INNOPEUTICS corporation

Filing Date

Dec 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

INNOPEUTICS Trademark

Serial Number: 79445256

INNOPEUTICS is a trademark filed by INNOPEUTICS corporation on December 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

INNOPEUTICS corporation

510 ho, (Seongsu-dong 2-ga,

Entity Type: 03

Trademark Details

Filing Date

December 18, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of viral diseases; pharmaceutical preparations for the treatment of leukemia; pharmaceutical preparations for the treatment of cells; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the prevention of disorders of the nervous system; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of central nervous system diseases

Filing History

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 5, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 5, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Apr 23, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 21, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 23, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 23, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 23, 2026 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 5, 2026 SDRC